AstraZeneca: News

10 Feb 2021

South Africa

South Africa scraps AstraZeneca vaccine, will give J&J jabs

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

04 Feb 2021


UK begins world's first alternate dosing COVID-19 vaccine trial

Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.

03 Feb 2021


Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study

According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.

03 Feb 2021


Russia's coronavirus vaccine approved for use in Mexico

Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.

02 Feb 2021


South Africa welcomes first delivery of COVID-19 vaccines

South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.

30 Jan 2021

Narendra Modi

Sri Lanka: No adverse reactions so far following vaccination

No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.

11 Jan 2021


Vaccine transport from SII to start from January 11/12

With the COVID-19 vaccination drive in India set to roll out on January 16, transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, is likely to start from the evening of January 11 or January 12, sources involved in logistics planning said on Sunday.

COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns

Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."

31 Dec 2020


UK's approval to Oxford-AstraZeneca vaccine paves way for India

The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.

30 Dec 2020

Oxford University

After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK

The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.

28 Dec 2020

Oxford University

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

23 Dec 2020


Awaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility

From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.

23 Dec 2020


Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week

The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.

22 Dec 2020

Vladimir Putin

Russia, AstraZeneca to test combination of COVID-19 shots

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

12 Dec 2020

Times of India

Here's how the government is planning to conduct COVID-19 vaccinations

With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.

Trial will continue: Centre on SII vaccine's "adverse reaction" claims

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

30 Nov 2020


SII to sue vaccine trial participant for Rs. 100 crore

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

26 Nov 2020


Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

23 Nov 2020


Oxford's vaccine, India's best shot against coronavirus, is 70% effective

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

Bharat Biotech vaccine trials continued despite 'adverse event' in August

Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

05 Nov 2020


Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

01 Nov 2020


Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

26 Oct 2020


Oxford COVID-19 vaccine generates immune response among young and old

The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.

22 Oct 2020


AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

20 Oct 2020


India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

13 Oct 2020

Johnson & Johnson

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

UK planning "challenge trials" that deliberately expose volunteers to COVID-19

With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.

12 Sep 2020


AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.

12 Sep 2020


Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

10 Sep 2020


Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

10 Sep 2020

University of Oxford

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

09 Sep 2020

United Kingdom

AstraZeneca halts coronavirus vaccine trial after volunteer falls ill

Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.

04 Sep 2020


#VaccineTracker: Early COVID-19 vaccine results expected by September 15

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

27 Aug 2020

Oxford University

Coronavirus vaccine tracker: When will one be ready?

The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.

30 Jul 2020


Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

24 Jul 2020

Oxford University

Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India

In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.

22 Jul 2020


As coronavirus pandemic surges, some vaccine makers expect to profit

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

17 Jul 2020


#GoodNews: Oxford's COVID-19 vaccine may be available by September-end

The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.

07 Jun 2020


COVID-19 vaccine: What are the latest updates?

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.